Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-008817
Filing Date
2017-10-05
Accepted
2017-10-05 17:06:22
Documents
10

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1702235
2 GRAPHIC g435316g95m56.jpg GRAPHIC 48485
3 GRAPHIC g435316g03u71.jpg GRAPHIC 69958
4 GRAPHIC g435316g13i80.jpg GRAPHIC 110727
5 GRAPHIC g435316g32w95.jpg GRAPHIC 70983
6 GRAPHIC g435316g35k19.jpg GRAPHIC 47691
7 GRAPHIC g435316g46s77.jpg GRAPHIC 83909
8 GRAPHIC g435316g51v04.jpg GRAPHIC 38240
9 GRAPHIC g435316g54q82.jpg GRAPHIC 93003
10 GRAPHIC g435316g79f09.jpg GRAPHIC 109572
  Complete submission text file 0000950123-17-008817.txt   2629396
Mailing Address 75 ARLINGTON STREET SUITE 500 BOSTON MA 02116
Business Address 75 ARLINGTON STREET SUITE 500 BOSTON MA 02116 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01701 | Film No.: 171125202
SIC: 2834 Pharmaceutical Preparations